Autolus Therapeutics (AUTL) Other Gross PP&E Adjustments (2017 - 2025)
Autolus Therapeutics posted quarterly Other Gross PP&E Adjustments of -$40.1 million for Q4 2025, little changed year-on-year from -$40.0 million in Q4 2024, and up 3.43% on a QoQ basis from -$41.5 million in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Other Gross PP&E Adjustments data on file, last reported at -$40.1 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments changed 0.13% year-over-year to -$40.1 million; the trailing twelve-month figure through Dec 2025 stood at -$40.1 million (changed 0.13% YoY), and the FY2025 full-year result was -$40.1 million, changed 0.13% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$40.1 million, up from -$41.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $10.5 million in Q4 2021 and bottomed at -$67.4 million in Q4 2023.
- The 5-year median for Other Gross PP&E Adjustments is -$30.0 million (2023), against an average of -$28.5 million.
- The widest annual swing landed in 2021, when Other Gross PP&E Adjustments jumped 119.62%; it then tumbled 2975.45% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $10.5 million in 2021, then plunged by 67.64% to $3.4 million in 2022, then sank by 2081.22% to -$67.4 million in 2023, then surged by 40.5% to -$40.1 million in 2024, then rose by 0.13% to -$40.1 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$40.1 million (Q4 2025), -$41.5 million (Q3 2025), and -$56.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -40.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.06 Mn |
| Dec 31, 2025 | -40.06 Mn |
| Sep 30, 2025 | -41.49 Mn |
| Sep 30, 2025 | -41.49 Mn |
| Jun 30, 2025 | -56.02 Mn |
| Jun 30, 2025 | -56.02 Mn |
| Mar 31, 2025 | -12.53 Mn |
| Mar 31, 2025 | -12.53 Mn |
| Dec 31, 2024 | -40.12 Mn |
| Dec 31, 2024 | -40.12 Mn |
| Sep 30, 2024 | -57.98 Mn |
| Sep 30, 2024 | -57.98 Mn |
| Jun 30, 2024 | -55.43 Mn |
| Jun 30, 2024 | -55.43 Mn |
| Mar 31, 2024 | -56.69 Mn |
| Mar 31, 2024 | -56.69 Mn |
| Dec 31, 2023 | -67.42 Mn |
| Dec 31, 2023 | -67.42 Mn |
| Sep 30, 2023 | -33.04 Mn |
| Sep 30, 2023 | -33.04 Mn |
| Jun 30, 2023 | -54.25 Mn |
| Jun 30, 2023 | -54.25 Mn |
| Mar 31, 2023 | -26.86 Mn |
| Mar 31, 2023 | -26.86 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Sep 30, 2022 | -13.24 Mn |
| Sep 30, 2022 | -13.24 Mn |
| Jun 30, 2022 | -1.76 Mn |
| Jun 30, 2022 | -1.76 Mn |
| Mar 31, 2022 | -904,000.00 |
| Mar 31, 2022 | -904,000.00 |
| Dec 31, 2021 | 10.52 Mn |
| Dec 31, 2021 | 10.52 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Sep 30, 2021 | -2.82 Mn |
| Jun 30, 2021 | -1.95 Mn |
| Jun 30, 2021 | -1.95 Mn |
| Mar 31, 2021 | -21.20 Mn |
| Mar 31, 2021 | -21.20 Mn |
| Dec 31, 2020 | -53.61 Mn |
| Dec 31, 2020 | -53.61 Mn |
| Sep 30, 2020 | -49.54 Mn |
| Sep 30, 2020 | -49.54 Mn |
| Jun 30, 2020 | -1.56 Mn |
| Jun 30, 2020 | -1.56 Mn |
| Mar 31, 2020 | -23.71 Mn |
| Mar 31, 2020 | -23.71 Mn |
| Dec 31, 2019 | -5.20 Mn |
| Dec 31, 2019 | -5.20 Mn |
| Sep 30, 2019 | -1.87 Mn |
| Sep 30, 2019 | -1.87 Mn |
| Jun 30, 2019 | -25.51 Mn |
| Jun 30, 2019 | -25.51 Mn |
| Mar 31, 2019 | -3.24 Mn |
| Mar 31, 2019 | -3.24 Mn |
| Dec 31, 2018 | -524,000.00 |
| Dec 31, 2018 | -524,000.00 |
| Sep 30, 2018 | 10.47 Mn |
| Sep 30, 2018 | 10.47 Mn |
| Sep 30, 2017 | 2.10 Mn |
| Sep 30, 2017 | 2.10 Mn |